For stage III melanoma patients, circulating tumor cells predict relapse.
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Researchers aimed to identify clinicopathologic characteristics of patients with stage III melanoma who would benefit from regular CNS imaging.
Although they comprise a small percentage of all published articles, articles with financial links to the indoor tanning industry are more likely to favor indoor tanning.
The need for skin examinations for patients with metastatic melanoma is evaluated in this novel study, which noted that a greater number of subsequent skin lesions were found by the patient.
Treatment and outcomes of nail apparatus melanoma are outlined in this study that finds a high survival rate—and that conservative treatment yields high patient satisfaction.
Patients are very satisfied with Mohs micrographic surgery (MMS) for melanoma in situ.
The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination.
Two treatments of combined AFL and IM show potential to treat low-risk BCCs with acceptable tolerability. OCT and RCM show promise to detect subclinical BCCs at short-term follow up.
From 2012 to 2014, 41,185 patients with a diagnosis of skin malignancy of the head and neck region were identified, mostly with a diagnosis of nonmelanoma skin cancer.